Roche Receives CE Mark for Mass Spectrometry Antibiotics Monitoring
The approval expands the company's automated mass spectrometry menu to 39 tests.
The approval expands the company's automated mass spectrometry menu to 39 tests.
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
The system helps healthcare experts better manage bacteremia by providing antibiotic susceptibility test results with improved speed.
A new gene expression-based test will help distinguish between bacterial and viral infections quickly, cutting down on antibiotic overuse.
Read MoreThe U.S. CDC states that antibiotic resistant infections are responsible for killing over a million people worldwide every year.
Read MoreThe diagnostic panel is ideal for clinicians seeking to quickly identify pathogens with precision and avoid overutilization of antibiotics.
Read MoreAccelerate Diagnostics announced the commercialization of its Accelerate Arc system, which includes the Accelerate Arc Module and BC kit.
Read MoreApproximately 1.27 million deaths were caused by bacterial antimicrobial resistance in 2019, more than fatalities caused by HIV/AIDS and malaria, combined.
Read MorePenicillin allergy testing during pregnancy may help avoid infant illness from infection, according to a new study from the ACAAI.
Read MoreA technique that measures the metabolic activity of bacteria with an electric probe can identify antibiotic resistance in less than 90 minutes.
Read MoreSelux Diagnostics, Inc. has received Breakthrough Device Designation for its Next Generation Phenotyping (NGP) platform.
Read MoreMoving diagnostic technology to the clinical setting is key to the fight against antibiotic resistance.
Read MoreThe nonexclusive agreement is intended to expand global access to SpeeDx infectious disease and antibiotic resistance tests and technology.
Read MoreThe system for assessing urinary tract infections at the point of care and determining an optimal antibiotic course is on track for initial trials in 2020.
Read MoreInflammatix’s HostDx fever test reads the immune system to rapidly diagnose acute infections at the point of care.
Read MoreRapid molecular diagnostics contribute to improved patient outcomes.
Read MoreThe test can be performed using pharyngeal, rectal, or urine samples, ensuring that complete care is provided for higher risk groups.
Read MoreThe partners intend to develop solutions to accelerate research on the growing public health threat of antibiotic resistance.
Read More